本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Quoin Pharmaceuticals

8.60
-0.1850-2.11%
盘后8.760.1600+1.86%16:04 EDT
成交量:2,611.00
成交额:2.27万
市值:505.82万
市盈率:-0.22
高:8.60
开:8.57
低:8.57
收:8.79
数据加载中...
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/11/12

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/08/10

SEC问询函

CORRESP [Cover] - Correspondence
2021/08/05

SEC问询函

CORRESP [Cover] - Correspondence
2021/08/03

交易所摘牌声明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2021/07/16

SEC问询函

CORRESP [Cover] - Correspondence
2021/03/29

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/13

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/08/04

[修订]年度报告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/04/22

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/04/03

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/01/17

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/01/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2019/06/20

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2019/03/18

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]